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Abstract
Background: Genome-wide association studies (GWAS) in Caucasians have identified fourteen index single nucleotide
polymorphisms (iSNPs) that influence colorectal cancer (CRC) risk.
Methods: We investigated the role of eleven iSNPs or surrogate SNPs (sSNPs), in high linkage disequilibrium (LD, r2$0.8)
and within 100 kb vicinity of iSNPs, in 2,000 age- and gender-matched Singapore Chinese (SCH) cases and controls.
Results: Only iSNP rs6983267 at 8q24.21 and sSNPs rs6695584, rs11986063, rs3087967, rs2059254, and rs7226855 at 1q41,
8q23.3, 11q23.1, 16q22.1 and 18q21.1 respectively showed evidence of association with CRC risk, with odds ratios (OR)
ranging from 1.13 to 1.40. sSNP rs827401 at 10p14 was associated with rectal cancer risk (OR = 0.74, 95% CI 0.63–0.88) but
not disease prognosis (OR= 0.91, 95% CI 0.69–1.20). Interestingly, sSNP rs3087967 at 11q23.1 was associated with CRC risk in
men (OR= 1.34, 95% CI 1.14–1.58) but not women (OR = 1.07, 95% CI: 0.88–1.29), suggesting a gender-specific role. Half of
the Caucasian-identified variants, including the recently fine-mapped BMP pathway loci, BMP4, GREM1, BMP2 and LAMA 5,
did not show any evidence for association with CRC in SCH (OR ,1; p-value .0.1). Comparing the results of this study with
that of the Northern and Hong Kong Chinese, only variants at chromosomes 8q24.21, 10p14, 11q23.1 and 18q21.1 were
replicated in at least two out of the three Chinese studies.
Conclusions: The contrasting results between Caucasians and Chinese could be due to different LD patterns and allelic
frequencies or genetic heterogeneity. The results suggest that additional common variants contributing to CRC
predisposition remained to be identified.
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Introduction
To date, GWAS in the Caucasian populations have uncovered
fourteen iSNPs at chromosomes 1q41, 3q26.2, 8q23.3, 8q24.21,
10p14, 11q23.1, 12q13.13, 14q22, 15q13.3, 16q22.1, 18q21.1,
19q13.1, 20p12.3 and 20q13.33 associated with CRC risk [1].
Fine mapping at several of these candidate regions have identified
other SNPs that could potentially be functional variants [2,3].
Since there are significant differences in allelic frequencies and LD
patterns across different populations, these variants have to be
replicated to ascertain their role in CRC. More than one-third of
these variants, for example, were found to have odds ratios in the
opposite direction in the African Americans [4].
Only five variants, rs6983267 (8q24.21), rs10795668 (10p14),
rs3802842 (11q23.1), rs4939827 (18q21.1) and rs961253 (20p12.3)
were replicated in Northern Chinese [5]. More recently, four
variants, rs7014346 (8q24.21), rs4779584 (15q13.3), rs10795668
(10p14) and rs4939827 (18q21.1) were replicated in Hong Kong
Chinese [6]. There is neither LD nor population structure
information in either study. Several reports indicated that there
is a ‘north-south’ population structure closely correlated to
geographic location and that the greatest genetic difference is
between the Northern Han and Southern Han Chinese [7,8].
We performed genome-wide genotyping on 2,000 age- and
gender-matched case-control series of Singapore Chinese (SCH)
patients from a single center and population-based healthy
controls. The SCH aged 50 years or more comprises mainly
descendants of immigrants from the Southern Chinese provinces
of Guangdong and Fujian, and is thus representative of the
Southern Han Chinese. Determining the genetic risk for CRC in
SCH is pertinent as the SCH has the highest CRC incidence
amongst all races in Singapore; internationally, its incidence is
higher than that of the residents of Shanghai, China and
comparable to that of the Caucasian Whites [9].
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Materials and Methods
Ethics Statement
Collection of samples and clinico-pathological information from
patients and controls was undertaken with written informed
consent and approval from SingHealth Centralized Institutional
Review Board B.
Sample Collection
Matched specimens of mucosa and tumor are routinely
collected and archived from patients undergoing resection at
Singapore General Hospital (SGH). SGH is the premier public
hospital which treats about half of the CRC patients in Singapore.
The matched mucosa specimens collected are typically at least
10 cm away from tumor site. Mucosa specimens from 1,000
sporadic Chinese CRC patients (defined as age 50 or more at date
of operation and without dominant family history of FAP and
HNPCC) archived over the past ten years were selected as cases
for the study.
Blood samples from 1,000 age- and gender-matched healthy
donors from the Singapore Chinese Health Study (SCHS)
(n = 931) [10] and the SGH Health Screening Unit (n = 69)
constituted the controls of the study. Age was matched to within
three years of the year of operation of the cases. The controls
were interviewed to ensure that they have no CRC family
history.
Genome-wide Genotyping
Sampleswere randomized so that consecutively procured samples
were not extracted consecutively. Genomic DNA was extracted
using standard procedures (Methods S1). Whole-genome scan was
performedwith Affymetrix GeneChipHumanMapping SNPArray
6.0 consisting 906, 600SNPs.A600 ng of genomicDNA samplewas
digested with the restriction enzymes NspI and StyI, amplified,
fragmented, labelled and hybridised to the Array for 16 h as per the
manufacturer’s instructions (Affymetrix, Santa Clara, CA). Arrays
were scanned with the Affymetrix 3000-7G scanner and analysed
with the Genotyping Console v3. CHP files were generated with the
Birdseed algorithm. To minimize batch effect, the genotyping was
performed by one operator; and matched cases and control
specimens were processed and arrayed together.
Statistical Analysis
The CHP (genotypes) files from the genome-wide scan were
imported into Golden Helix SVS for statistical analysis. SNP loci
that were not in Hardy-Weinberg Equilibrium (p#1E-7) in the
controls were filtered out. Principal component analysis (PCA) was
performed on 869, 371 autosomal SNPs on all 2,000 samples and
270 HapMap (consisting of 90 CEU, 45 Chinese Han Beijing
(CHB), 45 Japanese (JPT) and 90 Yoruba (YRB)) and 268
Singapore Genome Variant Project (SGVP) samples. The cases
and controls clustered with the CHB and the SGVP Chinese
samples indicating that there is no population substructure. Sixteen
outliers, including two controls that probably have admixture
ancestry, were removed. There was observable difference in the
clustering of cases and controls for PC1. This difference was no
longer apparent after PC1 correction (Figure S1).
Since the hypothesis tested in this study was whether the CEU-
identified SNPs for CRC risk can be replicated in the SCH, the
multiple testing corrections included only the number of at-risk
SNPs investigated. Thus, a Bonferroni correction of 0.0031 (0.05/
16) was applied. Multivariate logistic regression using the additive
model was performed after adjusting for PC1. SNPs with
p,0.0031 or 0.0031,p,0.1 were considered to be significantly
or showed a trend of being associated with disease risk respectively.
Subgroup analysis was performed for selected SNPs. The iSNPs
were examined whenever possible. If the iSNP was not found on
the SNP 6.0 platform or was non-polymorphic in SCH
(MAF,0.01), surrogate SNP (sSNP) in high L.D. (r2.0.8) and
within 100 kb vicinity of iSNP was identified from CHB
individuals from HapMap and examined. sSNPs that were
recently identified by fine mapping in CEU were interrogated
whenever possible [2,3]. The mean call rate of the eleven iSNPs
and sSNPs interrogated was 0.99 (ranging from 0.97 to 1) and the
genotypes of these SNPs clustered well.
Recurrence was defined as time from operation to local
recurrence and/or distant metastasis. All patients without recur-
rence up till January 31st 2012 were censored. Kaplan-Meier
analysis with log rank test was used to evaluate the relationship
between genotype and recurrence-free survival. Cox regression
test was used to test the independence of the covariates and to
estimate the risk for recurrence.
Results and Discussion
There were 14% more males than females in this cohort
(Table 1). Majority of the cases and controls were within the age
range of 61–80. About 2/3 of the cases had colon cancer while




No. (%) No. (%)
Sex
Male 565 (57.0) 566 (57.0)
Female 426 (43.0) 427 (43.0)
Age (y)
50–60 177 (17.9) 178 (17.9)
61–70 355 (35.8) 366 (36.9)
71–80 336 (33.9) 354 (35.7)
81–90 114 (11.5) 92 (9.3)
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early (Dukes A and B) and advanced (Dukes C and D) stages of
CRC were almost equally represented. Most of the CRC cases
were moderately differentiated. The clinico-pathological features
of the cases were representative of the Singapore CRC patients.
Three candidate regions have either no iSNPs on the Affymetrix
SNP6 platform (14q22 and 19q13.1) or the genotypes of iSNP
rs4925386 (20q13.33) clustered poorly. All three regions have no
sSNPs at high LD (r2$0.8) within 100 kb of the iSNPs, as
exemplified by the LD plot of chromosome 19q13.1 (Figure 1A).
Thus, it is unlikely that these candidate regions harbor any SNP
that could tag causal variant associated with CRC risk in SCH.
The only SNP out of the eleven interrogated that was
significantly associated with CRC risk in SCH was sSNP
rs3087967 at 11q23.1 (Figure 1B), possibly due to the higher
minor allelic frequencies (MAF) and the relatively higher effect size
(Table 2). Contrary to GWAS studies in Caucasians and Japanese
[11,12], we did not find this variant at 11q23.1 to be associated
with greater disease risk in the rectum (OR=1.20, 95% CI 1.02–
1.42) compared to colon (OR=1.22, 95% CI 1.06–1.41) (Table
S1). We, however, found rs3087967 to be associated with greater
CRC risk in men (OR=1.34, 95% CI 1.14–1.58; p= 0.0005)
compared to women (OR=1.07, 95% CI: 0.88–1.29; p = 0.4954),
thus implying a gender-specific role which has not been previously
reported. It is interesting to note, however, that iSNP rs3802842 at
11q23.1 was replicated in the Northern Chinese but not the Hong
Kong Chinese study [5,6]. It is unclear why this so but the Hong
Kong Chinese sampled could be a mixture of migrant workers
from all over China as Hong Kong is a cosmopolitan city.
Five SNPs, rs6687758, rs11986063,, rs6983267, rs2059254, and
rs7226855 at 1q41, 8q23.3, 8q24.21, 16q22.1 and 18q21.1
respectively show trend of association (0.0031,p,0.1) with
CRC in SCH but have not reached statistical significance
probably due to insufficient sample size and hence power
(Table 2). The MAF for these 5 SNPs were also smaller than
the CEU although the effect sizes were comparable.
The iSNP, rs6983267, at 8q24.21 was the first susceptible loci to
be identified in the Caucasians [13,14]. It was also the most
frequently replicated iSNP in several different populations
[5,11,15–17]. Interestingly, rs6983267 was reported to be
significantly associated with CRC risk in both the Japanese and
Northern Chinese in a recessive model only [5,15]. We found
rs6983267 to have higher effect size using a dominant model
instead in SCH (OR=1.38, 95% CI 1.13–1.69). It is unclear why
this is so but the Japanese were found to be genetically closer to
Northern Han Chinese than Southern Han Chinese [8]. The
Hong Kong study, however, did not find rs6983267 but another
SNP, rs7014346, at 8q24.21 to have evidence of association with
CRC risk [6].
Further, sSNP rs827401 at 10p14 was associated with decreased
cancer risk in rectum (OR=0.74, 95% CI 0.63–0.88; p = 0.0006)
but not colon (OR=1.02, 95% CI 0.89–1.18; p = 0.7466) in SCH
(Table S1), thus supporting earlier findings in the Caucasian and
Northern Chinese [5,18]. A recent study has reported that the
iSNP at 10p14 was associated with a reduced risk of recurrence
[19]. We, however, were not able to replicate this with sSNP
rs827401 in our rectal cancer patients. Kaplan-Meier analysis
revealed that the genotype was not significantly associated with
Figure 1. Local pairwise LD plots. The plots for SNPs at chromosomes 19q13.11 (A), 11q23.1 (B), 20p12.3 (C) and 20p12.3 (D) were derived from
SCH controls and HapMap CHB individuals respectively. Arrow and arrowhead indicate positions of iSNP and sSNPs interrogated. The sSNPs
interrogated at chromosomes 11q23.1 (B) and 20p12.3 (D) were rs3087967 and rs5005940 respectively. LD was measured as R2.
doi:10.1371/journal.pone.0042407.g001
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recurrence-free survival either in all patients or patients stratified
by chemotherapy. Patients with the protective allele (AB/BB) has
hazard ratio of 0.91 (95% CI 0.69–1.20, p = 0.50) with AA as
reference.
Notably, iSNPs rs7136702 (12q13.13) and rs4779584 (15q13.3)
and sSNPs rs12638862 (3q26.2) and rs5005940 (20p12.3) did not
show any evidence of being associated with CRC risk in SCH
(Table 2; OR,1; p-value .0.1). The report on Northern Chinese
found rs961253 at 20p12.3 to be significantly associated with CRC
risk (OR=1.38; 95% CI 1.19–1.60; p = 0.00002) [5]. We could
not replicate this finding with sSNP rs5005940 (OR=1.00; 95%
CI 0.79–1.28; p = 0.976) although the LD structure in SCH is
similar though not identical to the HapMap CHB samples
(Figure 1C and 1D), suggesting that genetic heterogeneity exists
between Northern and Southern Chinese. Similarly, rs4779584 at
15q13.13, with the risk allele being the major allele in the Chinese
(Table 2), was replicated in the Hong Kong Chinese but not the
Northern Chinese and SCH [5,6].
In summary, only iSNPs or sSNPs at 1q41, 8q23.3, 8q24.21,
11q23.1, 16q22.1 and 18q21.1 showed evidence of association
with CRC in SCH (Table 2). rs827401 at 10p14 was associated
with increased risk in rectal cancer only. Moreover, in contrast to
the findings of a recent study [19], the 10p14 region was not
associated with disease prognosis in our series. Susceptibility loci
from seven other candidate regions, 3q26.1, 12q13.13, 14q22,
15q13.3, 19q13.1, 20p12.3 and 20q13.3 showed no evidence of
being associated with the disease. It is noteworthy that all four
BMP loci, BMP4 (14q22), GREM1 (15q13.3), BMP2 (20p12.3) and
LAMA 5 (20q13.33), the BMP pathway genes highlighted in a
recent study [3], did not replicate in SCH. Chromosome 15q13.3
has been implicated to harbor the CRAC1/HMPS locus in
Ashkenazi Jewish hereditary mixed polyposis syndrome (HMPS)
patients [20]. We previously showed that the disease in Singapore
Chinese HMPS patients was not linked to 15q13.3, and identified
BMPR1A at 10q23 to be the disease-causing gene [21]. These
earlier results indicate that genetic heterogeneity can give rise to
similar clinical phenotypes in different populations.
Of the fourteen CEU-identified variants for CRC, only SNPs at
8q24.21, 10p14, 11q23.1 and 18q21.2 were replicated in at least
two out of the three Chinese populations, suggesting that the
functional variants in these regions could be important for
colorectal tumorigenesis across diverse populations (Table 3).
Amongst the four SNPs, only rs4939827 at 18q21.1 appear to tag
a gene, SMAD 7, in the TGF-aˆ signaling pathway, an important
pathway in colorectal tumorigenesis [22]. The other three SNPs
are in gene deserts. Accumulating evidence indicate that
rs6983267 at 8q24.1 lies within a long range enhancer regulating
the expression of C-MYC, an oncogene more than 300 kb
downstream by binding T cell factor 4 (TCF4) and enhancing Wnt
signaling [23–25]. Recent report has indicated, however, that
Table 2. Association of CEU-identified iSNP/sSNPs with CRC risk in SCH.
Chr Gene Symbol rsID* MAF1(CEU/CHB) MAF
2 Regression P O.R. (95% CI)
(SCH-control (Additive Model)
1q41 DUSP10 rs6695584 0.21/0.20 0.17 0.0864 1.16 (0.98, 1.36)
rs6687758 0.21/0.20
3q26.2 TERC rs12638862 0.27/0.58 0.55 0.7946 0.98 (0.87, 1.12)
MECOM
LRRC34 rs10936599 0.27/0.57
8q23.3 EIF3H rs16892766 0.11/0.004 0.0005
UTP23 rs11986063 0.12/0.06 0.04 0.0262 1.40 (1.04, 1.89)
8q24.21 POU5F1B rs6983267 0.49/0.39 0.44 0.042 1.15 (1.00, 1.31)
10p14 GATA3 rs827401 0.31/0.39 0.47 0.1383 0.91 (0.81, 1.03)
rs10795668 0.33/0.35
11q23.1 c11orf92 rs3087967 0.24/0.39 0.44 0.002a 1.22 (1.07, 1.38)
POU2AF1 rs3802842 0.24/0.39
12q13.13 DIP2B rs7136702 0.39/0.51 0.4 0.249 1.08 (0.95, 1.22)
ATF1
15q13.3 GREM1 rs4779584 0.17/0.82 0.81 0.5944 1.14 (0.94, 1.38)
16q22.1 CDH1 rs2059254 0.29/0.19 0.21 0.052 0.86 (0.73, 1.00)
rs9929218 0.29/0.20
18q21.1 SMAD7 rs4939827 0.47/0.24
rs7226855 0.47/0.25 0.33 0.0687 1.13 (0.99, 1.28)
20p12.3 FERMT1 rs961253 0.35/0.08
BMP2 rs5005940 0.40/0.07 0.07 0.976 1.00 (0.79, 1.28)
CEPH Europeans (CEU)-identified index and surrogate SNPs in bold and italics font respectively.
Singapore Chinese (SCH) surrogate SNPs that are different from the CEU i/sSNPs in normal font.
1Minor allele frequencies (Caucasian/Chinese Han Beijing) from HapMap Release 28.
2Note: Minor allele in CEU maybe major allele in SCH/CHB.
aSignificant after Bonferroni correction (P,0.0031).
SNP locations based on Human Genome build 36.
doi:10.1371/journal.pone.0042407.t002
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there is neither somatic loss of the risk allele nor possible functional
enhancer elements in the LD region at 10p14 and 11q23.1 [26],
implying therefore that other unknown mechanisms may be
responsible for the association.
In addition, the 8q23.3 region harboring the EIF3H and UTP23
genes could be potentially important risk region for the Chinese as
well, as sSNP rs11986063 was replicated with the highest effect
size in SCH. The 8q23.3 region was not interrogated in the other
two Chinese studies due to the lack of polymorphism in the iSNP
rs16892766. Pittman et al showed that SNP rs16888589 at 8q23.3
bind EIF3H promoter and repressed its transcription [27]. A later
eQTL expression analysis indicated however that the expression of
UTP23, rather than that of EIF3H, was correlated with the risk
allele of rs16888589 at 8q23.3. The authors suggested that both
genes could be functionally coordinated [2].
Not all CEU-identified variants were replicated in the Chinese.
The disparity could be due to differences in allelic frequencies and
LD structures or real genetic differences. Since the effect sizes of
these variants are relatively small and a recent study has estimated
that at least 60 common variants contribute to CRC risk [28], the
results imply that other variants contributing to predisposition to
CRC remained to be identified.
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